FujianCH
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
wei, Yang jian
NCT05314101: TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Recruiting
2
25
RoW
Tislelizumab, bevacizumab, TAS-102
Fujian Cancer Hospital
Immunotherapy, Colorectal Cancer
02/23
02/24
NCT06532058: Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Recruiting
2
53
RoW
QHRD107 capsule，Venclexta and Azacitidine, CDK9 inhibitors
Changzhou Qianhong Bio-pharma Co., Ltd.
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
02/25
05/25
NCT06897579: Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

Recruiting
2
134
RoW
Carboplatin for injection/cisplatin for injection + etoposide injection + benmelstobart injection + Anlotinib hydrochloride capsule, Carboplatin for injection/Cisplatin for injection + etoposide injection + Tislelizumab injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Extensive Stage Small Cell Lung Cancer
10/26
04/27
NCT06962865: A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

Not yet recruiting
2
80
RoW
RC108 plus Furmonertinib Mesilate Tablets, RC108 For Injection；, Furmonertinib (Oral)；, Furmonertinib Mesilate Tablets Monotherapy, Furmonertinib
RemeGen Co., Ltd.
Non-Small Cell Lung Cancer
05/26
12/27
NCT05673785: A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

Active, not recruiting
2
52
RoW
Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, Prednisone
Takeda
Lymphoma
04/25
12/27
chuan, Yang l
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
wei, Yang jian
NCT05314101: TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Recruiting
2
25
RoW
Tislelizumab, bevacizumab, TAS-102
Fujian Cancer Hospital
Immunotherapy, Colorectal Cancer
02/23
02/24
NCT06532058: Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Recruiting
2
53
RoW
QHRD107 capsule，Venclexta and Azacitidine, CDK9 inhibitors
Changzhou Qianhong Bio-pharma Co., Ltd.
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
02/25
05/25
NCT06897579: Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

Recruiting
2
134
RoW
Carboplatin for injection/cisplatin for injection + etoposide injection + benmelstobart injection + Anlotinib hydrochloride capsule, Carboplatin for injection/Cisplatin for injection + etoposide injection + Tislelizumab injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Extensive Stage Small Cell Lung Cancer
10/26
04/27
NCT06962865: A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

Not yet recruiting
2
80
RoW
RC108 plus Furmonertinib Mesilate Tablets, RC108 For Injection；, Furmonertinib (Oral)；, Furmonertinib Mesilate Tablets Monotherapy, Furmonertinib
RemeGen Co., Ltd.
Non-Small Cell Lung Cancer
05/26
12/27
NCT05673785: A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

Active, not recruiting
2
52
RoW
Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, Prednisone
Takeda
Lymphoma
04/25
12/27
chuan, Yang l
No trials found

Download Options